Getting to the evidence you really need to prove comparative value
A successfull evidence development program will bring out the most important features and benefits of your new treatment, But in order to design a precise and efficient plan, you first need to know the true characteristics of current treatment.
What is the averave prescribed dosage and duration treatment?
What about the incidence of overdose effects?
What is the frequency and intensity of monitoring?
Many types of retrospective data are now available electronically. The consultants within our Market Access Consulting Group can help you decide on, and extract from, the most appropriate source. In the context of a Late Phase Partnership with PAREXEL, they also offer the expertise to design and implement the required analysis.
Registry data tend to be high level.
Claims records offer a little more detail but are typically restricted to the population of a particular payer and may not always be generalizable.
Medical records offer a level of detail that is not usually available from other sources and also provide a means of linking activities and resource use between primary and secondary care.